Pesquisa

Edição
Título
Autores
Volume 30, Nº 3 (2023)
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
Biryukova E., Shinkin M., Morozova I.
PDF
(Rus)
Volume 30, Nº 1/2 (2023)
Relationship between non-alcoholic fatty liver disease and cardiovascular disease: focus on the use of ursodeoxycholic acid
Polyakova O., Tkachenko Y., Ostroumova O.
PDF
(Rus)
Volume 30, Nº 14 (2023)
Bempedoic acid – a new drug in lipid-lowering therapy
Leonova M.
PDF
(Rus)
Nº 9 (2017)
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
Shishkova V.
PDF
(Rus)
Nº 2 (2017)
Nonalcoholic fatty liver disease and cardiovascular risk (literature review)
Shirokova E.
PDF
(Rus)
Nº 1 (2009)
Cardio-vascular diseases in post-menopause (problems and ways of their solution)
Kirichenko A., Kirichenko A.
Volume 29, Nº 3 (2022)
Drug safety in real clinical practice: focus on protective therapy
Trukhan D., Ivanova D.
PDF
(Rus)
Nº 20 (2010)
EFFICACY OF OMEGA-3 POLYUNSATURATED FATTY ACID FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES: CURRENT STATE OF THE PROBLEM
Gilyarevskiy S., Gilyarevsky S.
Volume 29, Nº 4 (2022)
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
Novikova M., Koteshkova O., Antsiferov M.
PDF
(Rus)
Volume 27, Nº 13 (2020)
The role of the disturbances in the intestinal barrier structure in relation to cardiovascular diseases pathogenesis and rebamipid potential in their correction
Ostroumova O., Kochetkov A.
PDF
(Rus)
Nº 20 (2016)
CARDIORENAL RELATIONSHIPS IN PATIENTS WITH PRIMARY HYPOTHYROIDISM DEPENDING ON THE PHASE OF DISEASE
Nikolaeva A., Pimenov L.
PDF
(Rus)
Nº 15 (2010)
NONALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: INFLUENCE OF FEMALE SEX
Drapkina O., Korneev O., Drapkina O., Korneeva O.
Nº 15 (2009)
Arterial hypertension: importance of individual drugs selection and place of angiotensin-converting enzyme inhibitors in the treatment
Martynov A., Martinov A.
Volume 28, Nº 12 (2021)
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
Antsiferov M., Koteshkova O., Novikova M., Demidov N.
PDF
(Rus)
Nº 3 (2012)
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®)
Antsiferov M., Petunina N., Antsiferov M., Petunina N.
Nº 15 (2009)
Insulin resistance and heart diseases: is there a relationship?
Drapkina O., Smirin V., Ivashkin V., Drapkina O., Smirin V., Ivaschkin V.
Volume 27, Nº 5 (2020)
Beta-blockers in patients with chronic obstructive pulmonary disease: for whom, when, how?
Karoli N., Rebrov A.
PDF
(Rus)
Nº 15 (2009)
Phytosterins and cardiovascular diseases
Perova N., Perova N.
Nº 2s (2013)
SERDEChNO-SOSUDISTYE ZABOLEVANIYa I OSTEOPOROZ
Karpova N., Rashid M., Shostak N., Kazakova T.
PDF
(Rus)
Nº 15 (2011)
PLACE OF ASPIRIN IN THE THERAPY OF ATHEROTHROMBOSIS AND ITS COMPLICATIONS
Gilyarov M., Gilyarov M.
Nº 8 (2010)
Hawthorn (Crataegus): options for medical use
Samylina I., Sorokina A., Pyatigorskaya N., Samylina I., Sorokina A., Pyatigorskaya N.
Nº 17 (2012)
Sovremennye podkhody k lecheniyu dislipidemiy: differentsirovannaya gipolipidemicheskaya terapiya
Lupanov V.
PDF
(Rus)
Volume 29, Nº 11/12 (2022)
Hypothyroidism is an untimely diagnosed disease
Verbovoy A., Verbovaya N., Sharonova L.
PDF
(Rus)
Volume 28, Nº 3 (2021)
The relationship of cardiovascular disease with increased intestinal permeability: results from scientific and controlled clinical trials. Focus on the potential of rebamipide
Ostroumova O., Kochetkov A., Pavleeva E., Golovina O., Arablinsky N.
PDF
(Rus)
Nº 16 (2017)
Polymorbidity and modern medicine
Verbovoy A., Tsanava I., Verbovaya N., Galkin R., Madyanov I.
PDF
(Rus)
Nº 16 (2016)
Diabetes mellitus and coronary artery disease: features of clinical manifestation and treatment
Verbovoy A., Sharonova L.
PDF
(Rus)
Nº 15 (2013)
Vozmozhnosti primeneniya beta-adrenoblokatorov v lechenii serdechnososudistykh zabolevaniy u bol'nykh khronicheskoy obstruktivnoy bolezn'yu legkikh
Statsenko M., Derevyanchenko M.
PDF
(Rus)
Nº 6 (2009)
Anxiety and depression as risk factors of cardiovascular diseases: possibilities of medicamentous correction
Makolkin V., Makolkin V.
Volume 29, Nº 6 (2022)
Is there a «window of therapeutic opportunity» for testosterone replacement therapy for age-related hypogonadism in men?
Apetov S., Apetova V.
PDF
(Rus)
Nº 15 (2017)
Energy metabolism corrector Mildronate®: interrelation of mechanisms of action and therapeutic effects
Dzerve V.
PDF
(Rus)
Nº 7 (2010)
Psychiatric disturbances in cardiological practice
Artyukhova M., Artuhova M.
1 - 31 de 31 resultados
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies